Cargando…

Anidulafungin compared with fluconazole therapy in critically ill patients

Detalles Bibliográficos
Autores principales:	Kett, DH, Shorr, AF, Reboli, AC, Reisman, AC, Biswas, P, Schlamm, HT
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933999/ http://dx.doi.org/10.1186/cc8304

Ejemplares similares

Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis
por: Kett, Daniel H, et al.
Publicado: (2011)

Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome
por: Reboli, Annette C, et al.
Publicado: (2011)

Cost-effectiveness analysis of anidulafungin in the treatment of candidaemia
por: Auzinger, G, et al.
Publicado: (2013)

Predicting methicillin-resistant Staphylococcus aureus in critically ill patients with pneumonia presenting to the hospital
por: Shorr, AF, et al.
Publicado: (2012)

Anidulafungin for candidemia/invasive candidiasis in non-neutropenic ICU patients
por: Ruhnke, M, et al.
Publicado: (2011)

Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial
por: Vazquez, Jose, et al.
Publicado: (2014)

Early phenotypic detection of fluconazole- and anidulafungin-resistant Candida glabrata isolates
por: Georgiou, Panagiota-Christina, et al.
Publicado: (2022)

Evaluation of the nurse care given to critically ill patients through quality indicators
por: Chiarello, AC, et al.
Publicado: (2007)

Post-antifungal effect of the combination of anidulafungin with amphotericin B and fluconazole against fluconazole-susceptible and -resistant Candida albicans
por: Vaseghi, Narges, et al.
Publicado: (2022)

Peripherally inserted central catheter in critically ill patients
por: Lamblet, LCR, et al.
Publicado: (2005)

Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients
por: Ruhnke, M, et al.
Publicado: (2012)

Functional independence profile of critically ill patients
por: Timenetsky, Karina Tavares, et al.
Publicado: (2015)

Overuse of coagulation parameter testing in critically ill patients
por: Bibeau, V, et al.
Publicado: (2011)

Metabolic acid–base status of critically ill septic patients: a quantitative longitudinal study
por: Noritomi, DT, et al.
Publicado: (2005)

Do we spend less on older critically ill patients? Relationship among intensity of care, severity of illness and mortality
por: Rosa, MD, et al.
Publicado: (2014)

In Vitro and In Vivo Activity of Citral in Combination with Amphotericin B, Anidulafungin and Fluconazole against Candida auris Isolates
por: de-la-Fuente, Iñigo, et al.
Publicado: (2023)

Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis
por: Auzinger, Georg, et al.
Publicado: (2015)

Chronically critically ill patients: different behavior in severe sepsis and septic shock?
por: Prevedello, DH, et al.
Publicado: (2015)

Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study
por: van der Geest, Patrick J., et al.
Publicado: (2016)

Any level of acute kidney injury may be associated with mortality in critically ill patients
por: Rucks, AP, et al.
Publicado: (2011)

66 Evaluation of the particle immunofiltration anti-platelet factor 4 rapid assay in MICU patients with thrombocytopenia
por: Andrews, DM, et al.
Publicado: (2010)

Fluconazole-induced erythema fixum and edema of the upper lip
por: Valerieva, Anna, et al.
Publicado: (2014)

Fluconazole - a case report on fixed drug eruption
por: Correia, Magna, et al.
Publicado: (2014)

The apache ii and serum sodium levels as predictors of mortality in the surgical critically ill patients
por: Basile-Filho, A, et al.
Publicado: (2015)

Corticosteroids for critically ill patients: an international survey of intensivists
por: Lamontagne, F, et al.
Publicado: (2012)

Recombinant human erythropoietin therapy in critically ill patients
por: Georgopoulos, D, et al.
Publicado: (2005)

Cortisol metabolism in critical illness: effects of intensive insulin therapy
por: Vanhorebeek, I, et al.
Publicado: (2005)

Descriptive analysis of ICU patients with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia at four academic medical centers
por: Kett, DH, et al.
Publicado: (2008)

Implementing national guidelines in intensive care patients with ventilator-associated, hospital-acquired, and healthcare-associated pneumonia: the IMPACT-HAP project
por: Kett, DH, et al.
Publicado: (2008)

Procalcitonin in the critically ill
por: Kazda, A, et al.
Publicado: (2005)

Long Term Mortality in Critically Ill Burn Survivors
por: Nitzschke, SL, et al.
Publicado: (2015)

Insulin signaling in critical illness: intensive versus conventional insulin therapy
por: Langouche, L, et al.
Publicado: (2005)

Mechanisms of kidney protection by intensive insulin therapy during critical illness
por: Vanhorebeek, I, et al.
Publicado: (2008)

Nicotine replacement therapy is associated with improved outcomes in critically ill smokers
por: Bostaji, S, et al.
Publicado: (2008)

Anaphylactic reactions during oral food challenge test in pediatric patients
por: Gushken, AF, et al.
Publicado: (2013)

Longitudinal evaluation of intensive care unit-related fluconazole use in Spain and Germany
por: Wissing, H, et al.
Publicado: (2007)

Survival of critically ill patients with haematological malignancies compared with patients without haematological malignancy
por: Pugh, R, et al.
Publicado: (2013)

Influence of severity of illness on the effects of eritoran tetrasodium (E5564), a TLR4 antagonist, in patients with severe sepsis
por: Opal, SM, et al.
Publicado: (2009)

The Critically Ill Adults scale
por: Schoonderbeek, J, et al.
Publicado: (2005)

Dysmagnesaemia and Critical Illness Outcomes
por: Homer, LE, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i7c2q9h1hfofni17snatv9mvjc